Surrogate Marker

Preferred Label : Surrogate Marker;

NCIt definition : In a clinical trial, an assessment of an intervention's effects that takes the place of a patient-based conclusion.;

Alternative definition : CDISC-GLOSS: A measurement of a drug's biological activity that substitutes for a clinically meaningful endpoint. [After Russell Katz, Biomarkers and Surrogate Markers: An FDA Perspective, NeuroRx. 2004 Apr;1(2):189-95.];

Details

Origin ID

C142724;

UMLS CUI

C0086589;

Currated CISMeF NLP mapping
- surrogate markers [MeSH concept]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]
UMLS correspondences (same concept)
- surrogate markers [MeSH concept]
Validated automatic mappings to NTBT
- Biomarkers [MeSH Descriptor]
concept_is_in_subset
- CDISC Glossary Terminology [NCIt concept]
- Clinical Data Interchange Standards Consortium Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients